GTC at ASH 2021
GTC is excited to be exhibiting at ASH for the first time and look forward to meeting people in person. Our booth # 3440 and would
November 18, 2021 11:39 am
Publications
Read More »
Article
GTC scientists contribute to major study published in Journal of Clinical Oncology: Prediction of outcome in CLL patients
GTC scientists collaborate with the NIH on a study just published in the Journal of Clinical Oncology. The publication is titled: Prediction of outcome in
October 8, 2020 10:45 am
Press Releases
GTC research is being presented at ASCO 2020
GTC research is being presented at ASCO 2020 in the following three abstracts. 1. FGFR expression, fusion and mutation as detected by NGS sequencing of
May 20, 2020 9:50 am
Press Releases
American Society of Hematology Meeting 2019: PRESENTATION POSTERS
(Click photo to download the pdf file)
December 12, 2019 10:51 am
Press Releases
Study shows that RNA Plus DNA profiling significantly enhanced Drug Matching
Recent study published in Nature Medicine (Rodon et al, Nature Medicine volume 25, pages 751–758, 2019) showed that molecular profiling using both DNA and RNA
May 16, 2019 9:18 am
Acute Lymphoblastic Leukemia | Just published: A consensus of North American experts
Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts The vast majority of
November 30, 2018 5:56 am
Validation of Clinical Prognostic Models and Integration of Genetic Biomarkers | ASH ANNUAL MEETING ABSTRACT
Dr. Albitar’s molecular work is presented at the ASH meeting in oral and poster presentations. Validation of Clinical Prognostic Models and Integration of Genetic Biomarkers
November 29, 2018 5:46 am
Venetoclax in Combination with FLAG-IDA Chemotherapy (FLAG-V-I) for Fit | ASH ANNUAL MEETING ABSTRACT
Dr. Albitar’s molecular work is presented at the ASH meeting in oral and poster presentations Program: Oral and Poster Abstracts | Monday, December 3, 2018,
November 28, 2018 5:27 am
Genomics
Acute Myeloid Leukemia | ASH Annual Meeting Abstract
Session: 613. Acute Myeloid Leukemia: Clinical Studies: Poster I Molecular Epidemiologic Associations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) within the United States
November 26, 2018 7:50 am
Genomics
Deep Sequencing
Deep Sequencing of Cell-Free Peripheral Blood DNA as a Reliable Method for Confirming the Diagnosis of Myelodysplastic Syndrome. BACKGROUND: Demonstrating the presence of myelodysplastic syndrome
September 24, 2018 2:27 am